BDX

NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

Dollar change +1.81
Percentage change 0.88	%

Peers: JNJ ABT DHR BAX TMO ISRG HOLX BSX ALGN XRAY

| Held by: VTI VOO SPY IVV VTV XLV VIG VYM VHT IHI

Scroll to Statements

Index	S&P 500	P/E	34.30	EPS (ttm)	6.02	Insider Own	0.19%	Shs Outstand	287.14M	Perf Week	3.28%
Market Cap	59.28B	Forward P/E	13.18	EPS next Y	15.66	Insider Trans	-2.71%	Shs Float	286.60M	Perf Month	-9.26%
Income	1.75B	PEG	3.81	EPS next Q	3.28	Inst Own	92.82%	Short Float	1.42%	Perf Quarter	-17.12%
Sales	20.64B	P/S	2.87	EPS this Y	9.78%	Inst Trans	1.34%	Short Ratio	1.85	Perf Half Y	-13.49%
Book/sh	87.78	P/B	2.35	EPS next Y	8.55%	ROA	3.27%	Short Interest	4.07M	Perf Year	-10.43%
Cash/sh	2.89	P/C	71.42	EPS next 5Y	9.01%	ROE	6.92%	52W Range	193.03 - 251.99	Perf YTD	-9.01%
Dividend Est.	3.88 (1.88%)	P/FCF	20.19	EPS past 5Y	8.27%	ROI	4.10%	52W High	-18.07%	Beta	0.33
Dividend TTM	3.98 (1.93%)	Quick Ratio	0.63	Sales past 5Y	4.72%	Gross Margin	45.35%	52W Low	6.95%	ATR (14)	5.73
Dividend Ex-Date	Mar 10, 2025	Current Ratio	1.13	EPS Y/Y TTM	42.05%	Oper. Margin	14.13%	RSI (14)	44.93	Volatility	2.08% 3.35%
Employees	74000	Debt/Eq	0.74	Sales Y/Y TTM	5.89%	Profit Margin	8.47%	Recom	1.68	Target Price	267.67
Option/Short	Yes / Yes	LT Debt/Eq	0.69	EPS Q/Q	8.20%	Payout	64.86%	Rel Volume	0.50	Prev Close	204.63
Sales Surprise	1.33%	EPS Surprise	15.18%	Sales Q/Q	9.82%	Earnings	May 01 BMO	Avg Volume	2.20M	Price	206.44
SMA20	0.12%	SMA50	-5.74%	SMA200	-10.27%	Trades		Volume	1,095,281	Change	0.88%

Date	Action	Analyst	Rating Change	Price Target Change
Oct-01-24	Upgrade	Citigroup	Neutral → Buy	$255 → $275
May-30-24	Initiated	Goldman	Buy	$274
Jul-24-23	Upgrade	Raymond James	Mkt Perform → Outperform	$305
May-30-23	Resumed	Morgan Stanley	Overweight	$295
May-05-23	Upgrade	Piper Sandler	Neutral → Overweight	$260 → $290
Apr-12-23	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight	$304
Jan-03-23	Upgrade	BofA Securities	Neutral → Buy	$250 → $290
Dec-12-22	Upgrade	Citigroup	Sell → Neutral	$221 → $250
Jul-11-22	Downgrade	Citigroup	Neutral → Sell	$265 → $235
Jun-24-22	Upgrade	Wells Fargo	Equal Weight → Overweight	$275
Mar-18-22	Resumed	Raymond James	Mkt Perform
Mar-02-22	Resumed	BofA Securities	Neutral	$290
Dec-08-21	Downgrade	Piper Sandler	Overweight → Neutral	$285 → $260
Aug-06-21	Downgrade	JP Morgan	Overweight → Neutral	$265
May-25-21	Initiated	Barclays	Equal Weight	$270
Dec-15-20	Upgrade	Morgan Stanley	Equal-Weight → Overweight	$297
Dec-15-20	Downgrade	Wells Fargo	Overweight → Equal Weight	$265
Jul-09-20	Upgrade	Barclays	Equal Weight → Overweight	$300
Jun-01-20	Resumed	Goldman	Buy	$278
Mar-05-20	Initiated	Citigroup	Neutral	$260

Show Previous Ratings

Apr-29-25 08:07PM	Best Dividend Aristocrats For May 2025 (Seeking Alpha)
04:20PM	BD Board Declares Dividend (PR Newswire)
01:08PM	Can Sustained Product Demand Drive CAH Stock Before Q3 Earnings? (Zacks)
Apr-28-25 12:20PM	Can Sustained Product Demand Drive BDX Stock Before Q2 Earnings? (Zacks)
09:15AM	Gear Up for Becton Dickinson (BDX) Q2 Earnings: Wall Street Estimates for Key Metrics (Zacks)
06:11AM	Loading…
06:11AM	ClearBridge Dividend Strategy Fund Q1 2025 Commentary (Seeking Alpha)
Apr-27-25 01:17AM	Becton, Dickinson and Company: It's Wait And See For Me (Seeking Alpha)
Apr-25-25 08:18AM	Hologic Set to Report Q2 Earnings: Buy, Sell or Hold the Stock? (Zacks)
Apr-24-25 05:05AM	BDs umbilical hernia patch secures FDA 510(k) clearance (Medical Device Network)
Apr-23-25 12:27PM	You cant out-trade tariffs as stocks move in tandem (Bloomberg)
09:58AM	2025 Dividend Kings: Weathering Tariff Volatility Better Than The Market (Seeking Alpha)
06:50AM	BD Launches Industry-First Bioabsorbable Mesh Designed for Umbilical Hernia Repair (PR Newswire)
Apr-22-25 11:30AM	BD Stock Down Despite Monitoring Platform Launch to Boost Patient Care (Zacks)
06:01AM	BD introduces AI-based haemodynamic monitoring platform (Medical Device Network)
Apr-21-25 07:35AM	BD Launches Next Generation Hemodynamic Monitoring Solution Providing Clinicians with AI-Driven Clinical Decision Support (PR Newswire)
09:33PM	Loading…
Apr-17-25 09:33PM	DGI For The DIY: 2024 Dividend Portfolio Review (Seeking Alpha)
Apr-16-25 03:47PM	Is Becton, Dickinson and Company (BDX) the Best Dividend Monarch to Invest in Now? (Insider Monkey)
Apr-10-25 01:06PM	BD, Teleflex, Insulet, UFP Technologies, and Haemonetics Shares Are Falling, What You Need To Know (StockStory)
Apr-08-25 06:46AM	BD Seeks Potential Buyers for Life Sciences Business Division (Zacks)
Apr-07-25 09:40AM	Are You a Value Investor? This 1 Stock Could Be the Perfect Pick (Zacks)
Apr-04-25 07:47PM	Analyst Report: Becton, Dickinson and Company (Morningstar Research) -6.43%
08:20AM	Should You be Confident in Becton, Dickinson and Company's (BDX) Ability to Deliver Long-Term Returns? (Insider Monkey)
Apr-03-25 04:15PM	BD to Announce Financial Results for its Second Quarter of Fiscal 2025 (PR Newswire)
Mar-31-25 04:07PM	Best Dividend Aristocrats For April 2025 (Seeking Alpha)
06:50AM	BD Named One of America's Most Innovative Companies by Fortune (PR Newswire)
Mar-30-25 01:14PM	Becton Dickinson Could Be Cure To Demand For Medtech Supplies, With Robust Pipeline (Seeking Alpha)
Mar-28-25 08:24AM	Here's What Positions Becton, Dickinson and Company (BDX) Favorably in the Health Care Sector (Insider Monkey)
Mar-27-25 04:15PM	BD Names Gregory J. Hayes to Board of Directors (PR Newswire)
11:30AM	ClearBridge Large Cap Value Fund Q4 2024 Commentary (SeekingAlpha)
Mar-26-25 06:33AM	BDX Stock Declines Following Class I Classification for Alaris Recall (Zacks)
10:21AM	Loading…
Mar-24-25 10:21AM	BDX Shares May Climb as GalaFLEX LITE Trial Hits Key Milestone (Zacks)
Mar-22-25 03:15PM	Was Jim Cramer Right About Becton, Dickinson and Company (BDX)? (InsiderMonkey)
01:40AM	The Davenport Balanced Income Fund Q4 2024 Commentary (SeekingAlpha)
12:31AM	Dividend Champion, Contender, And Challenger Highlights: Week Of March 23 (SeekingAlpha)
Mar-21-25 12:59PM	2025 Dividend Kings: Strong Run Continues (SeekingAlpha)
12:25PM	FDA tags Becton, Dickinson and Company infusion software recall as Class I (Medical Device Network)
12:20PM	The Davenport Value & Income Fund Q4 2024 Commentary (SeekingAlpha)
11:31AM	BD treats first subject in trial of bioabsorbable scaffold (Medical Device Network)
10:05AM	Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term (Zacks)
Mar-20-25 06:50AM	BD Announces Milestone in Clinical Trial for Use of Bioabsorbable GalaFLEX LITE Scaffold in Breast Implant Revision Surgery (PR Newswire)
Mar-19-25 09:40AM	Here's Why Becton Dickinson (BDX) is a Strong Value Stock (Zacks)
Mar-18-25 09:50AM	Here's Why Becton Dickinson (BDX) is a Strong Momentum Stock (Zacks)
Mar-10-25 05:06AM	BD (NYSE:BDX): Strongest Q4 Results from the Surgical Equipment & Consumables - Diversified Group (StockStory)
Feb-28-25 09:45AM	Here's Why Becton Dickinson (BDX) is a Strong Growth Stock (Zacks)
04:07AM	3 Reasons to Sell BDX and 1 Stock to Buy Instead (StockStory)
Feb-27-25 09:40AM	Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term (Zacks)
Feb-20-25 05:23AM	BD business separation could allow competitors to rise in IVD test markets (Medical Device Network)
Feb-18-25 08:30AM	Do Options Traders Know Something About BD (BDX) Stock We Don't? (Zacks)
Feb-13-25 04:15PM	BD to Present at Investor Healthcare Conferences (PR Newswire)
Feb-12-25 09:45AM	Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term (Zacks)
Feb-07-25 12:43PM	BD business split may prefigure life sciences division selloff (Medical Device Network)
09:30AM	Becton Dickinson price target raised to $269 from $265 at BofA (TipRanks)
02:07AM	Becton Dickinson & Co (BDX) Q1 2025 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
12:08AM	Q1 2025 Becton Dickinson and Co Earnings Call (Thomson Reuters StreetEvents)
Feb-06-25 01:50PM	Becton Dickinson to Separate Biosciences and Diagnostic Solutions Business (GuruFocus.com) -7.28%
12:31PM	Analyst Report: Becton, Dickinson and Company (Morningstar Research)
10:24AM	Becton Dickinson Q1 Earnings: Revenue And EPS Beat, Lowers Outlook, Outlines Intent To Separate Biosciences And Diagnostic Solutions Business (Benzinga)
Feb-05-25 06:30PM	Compared to Estimates, Becton Dickinson (BDX) Q1 Earnings: A Look at Key Metrics (Zacks)
05:55PM	Becton Dickinson (BDX) Tops Q1 Earnings and Revenue Estimates (Zacks)
05:02PM	Becton Dickinson to Separate From Bioscience and Diagnostic Solutions Business (The Wall Street Journal)
04:49PM	Becton Dickinson: Fiscal Q1 Earnings Snapshot (Associated Press Finance)
04:30PM	BD Reports First Quarter Fiscal 2025 Financial Results (PR Newswire)
04:30PM	BD Announces Intent to Separate Biosciences and Diagnostic Solutions Business to Enhance Focus, Drive Growth and Unlock Value (PR Newswire)
08:07AM	BD (BDX) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Feb-03-25 09:16AM	Insights Into Becton Dickinson (BDX) Q1: Wall Street Projections for Key Metrics (Zacks)
09:09AM	Analyst Report: Becton, Dickinson and Company (Morningstar Research)
Jan-30-25 10:01AM	Becton Dickinson (BDX) Reports Next Week: Wall Street Expects Earnings Growth (Zacks)
Jan-28-25 04:15PM	BD Board Declares Dividend, Authorizes 10 Million Additional Share Repurchases; BD Completed $750 Million Repurchase to Date in FY25 (PR Newswire)
05:30AM	DEI Pay Incentives Come Under Pressure After Two-Year Surge (The Wall Street Journal)
Jan-24-25 12:27PM	Alphabet, Uber, Applied Materials, and 19 Other Picks From the Barrons Roundtable (Barrons.com)
Jan-23-25 07:15AM	BD and Biosero Collaborate to Enable Robotic Integration with Flow Cytometers Used in Drug Discovery and Development (PR Newswire)
Jan-22-25 11:07AM	Carilion to use BDs needle-free blood draw device (Medical Device Network)
06:50AM	Carilion Clinic First in Virginia to Offer Needle-free In-patient Blood Draws, Redefining Patient Standard of Care (PR Newswire)
Jan-21-25 05:22PM	Masimo Taps Katie Szyman as Permanent CEO (The Wall Street Journal)
Jan-16-25 04:15PM	BD to Announce Financial Results for its First Quarter of Fiscal 2025 (PR Newswire)
Jan-15-25 08:56AM	Is Becton, Dickinson and Company (BDX) an Undervalued Stock? (Insider Monkey)
06:50AM	New Survey Reveals Nearly 3 in 4 Canadian Women Are Delaying Their OB/GYN Exams, Increasing Risks for Cervical Cancer (PR Newswire)
06:50AM	BD Boosts U.S. Manufacturing of Critical Medical Devices (PR Newswire)
Jan-14-25 02:06PM	3 in 4 women are skipping a routine appointment and putting themselves at higher risk for cancer (Fortune)
Jan-13-25 06:50AM	New ASCCP Guidelines Include More Precise Method of Cervical Cancer Screening (PR Newswire)
Jan-10-25 09:44AM	The Forgotten Four (GuruFocus.com)
06:50AM	BD Names Pamela Spikner as Chief Accounting Officer and Controller (PR Newswire)
Jan-09-25 09:45AM	Here's Why Becton Dickinson (BDX) is a Strong Growth Stock (Zacks)
06:50AM	New Survey Finds Women Are Skipping Their OB/GYN Exams, Increasing Risks for Cervical Cancer (PR Newswire)
Jan-07-25 04:15PM	BD To Host Virtual 2025 Annual Meeting of Shareholders (PR Newswire)
12:10PM	Will Becton Dickinson (BDX) Beat Estimates Again in Its Next Earnings Report? (Zacks)
Jan-03-25 09:40AM	Becton Dickinson (BDX) is a Top-Ranked Value Stock: Should You Buy? (Zacks)
Dec-20-24 09:45AM	Why Becton Dickinson (BDX) is a Top Growth Stock for the Long-Term (Zacks)
Dec-18-24 09:40AM	Here's Why Becton Dickinson (BDX) is a Strong Value Stock (Zacks)
06:18AM	BD and Babson expand fingertip blood testing across US health systems (Medical Device Network)
Dec-17-24 09:50AM	Why Becton Dickinson (BDX) is a Top Momentum Stock for the Long-Term (Zacks)
06:50AM	BD and Babson Diagnostics Launch Innovative Fingertip Blood Testing to Health Care Organizations (PR Newswire)
Dec-16-24 05:52PM	Becton Dickinson to Pay $175 Million to Settle SEC Probe (Bloomberg)
04:46PM	Becton Dickinson settles charges over infusion pump risks, SEC says (Reuters)
04:32PM	BD Resolves Previously Disclosed SEC Investigation (PR Newswire)
08:08AM	Heres Why Matrix Asset Advisors Added Becton, Dickinson and Company (BDX) (Insider Monkey)
Dec-14-24 06:19AM	These 10 most-loved S&P 500 stocks could see as much as 50% upside in 2025 (MarketWatch)
12:10AM	Why Is Becton, Dickinson and Company (BDX) Among the Best Income Stocks to Buy According to Analysts? (Insider Monkey)
Dec-05-24 04:05PM	Maravai LifeSciences Appoints R. Andrew Eckert as Chairman of the Board of Directors (GlobeNewswire)
Dec-02-24 02:21PM	Why Becton Dickinson (BDX) is a Top Value Stock for the Long-Term (Zacks)

Becton, Dickinson & Co. is a global medical technology company, which engages in the development, manufacture, and sale of medical supplies, devices, laboratory equipment, and diagnostic products. It operates through the following segments: BD Medical, BD Life Sciences, and BD Interventional. The BD Medical segment produces medical technologies and devices that are used to help improve healthcare delivery. The BD Life Sciences segment provides products for the safe collection and transport of diagnostics specimens, instruments, and reagent systems to detect infectious diseases, healthcare-associated infections, and cancers. The BD Interventional segment offers vascular, urology, oncology, and surgical specialty products to hospitals, ambulatory surgery centers, individual healthcare professionals, extended care facilities, alternate site facilities, and patients via its Homecare business. The company was founded by Maxwell W. Becton and Fairleigh S. Dickinson in 1897 and is headquartered in Franklin Lakes, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Garrison Michael David	EVP & President, Medical	Apr 09 '25	Sale	197.28	479	94,497	4,887	Apr 10 01:56 PM
MICHAEL GARRISON	Officer	Apr 09 '25	Proposed Sale	200.83	479	96,198		Apr 09 04:16 PM
Byrd Richard	EVP & President Interventional	Mar 18 '25	Sale	230.00	459	105,570	6,952	Mar 19 01:55 PM
RICHARD BYRD	Officer	Mar 18 '25	Proposed Sale	227.83	459	104,574		Mar 18 04:33 PM
Byrd Richard	EVP & President Interventional	Mar 12 '25	Sale	224.91	1,940	436,325	7,411	Mar 13 01:03 PM
RICHARD BYRD	Officer	Mar 12 '25	Proposed Sale	224.92	1,940	436,345		Mar 12 04:22 PM
SCOTT BERTRAM L	Director	Feb 12 '25	Sale	227.99	700	159,593	36,033	Feb 12 04:44 PM
BERTRAM SCOTT	Director	Feb 12 '25	Proposed Sale	227.99	700	159,593		Feb 12 04:12 PM
Henderson Jeffrey William	Director	Feb 10 '25	Buy	233.62	1,500	350,430	8,015	Feb 10 05:03 PM
Shan David	EVP and Chief ISC Officer	Jan 21 '25	Sale	240.00	500	120,000	5,741	Jan 22 09:19 AM
Neal Shana Carol	EVP and Chief People Officer	Jan 21 '25	Sale	240.00	787	188,880	15,414	Jan 22 09:18 AM
SHANA NEAL	Officer	Jan 21 '25	Proposed Sale	237.38	787	186,818		Jan 21 04:21 PM
DAVID SHAN	Officer	Jan 21 '25	Proposed Sale	237.38	500	118,690		Jan 21 01:47 PM
Garrison Michael David	EVP & President, Medical	Jan 17 '25	Sale	236.51	597	141,196	5,544	Jan 21 08:21 AM
MICHAEL GARRISON	Officer	Jan 17 '25	Proposed Sale	236.30	597	141,071		Jan 17 04:20 PM
Neal Shana Carol	EVP and Chief People Officer	Nov 21 '24	Option Exercise	0.00	111	0	17,021	Jan 10 07:11 AM
Neal Shana Carol	EVP and Chief People Officer	Jan 07 '25	Sale	235.00	788	185,180	16,201	Jan 10 07:11 AM
SHANA NEAL	Officer	Jan 07 '25	Proposed Sale	230.70	788	181,792		Jan 07 04:19 PM
Garrison Michael David	EVP & President, Medical	Dec 19 '24	Sale	223.33	2,838	633,811	6,141	Dec 20 10:18 AM
MICHAEL GARRISON	Officer	Dec 19 '24	Proposed Sale	224.09	2,838	635,967		Dec 19 04:20 PM
Goette Roland	EVP and President, EMEA	Dec 06 '24	Option Exercise	157.30	13,334	2,097,403	28,828	Dec 10 08:23 PM
Goette Roland	EVP and President, EMEA	Dec 06 '24	Sale	221.01	4,483	990,788	24,345	Dec 10 08:23 PM
Goette Roland	EVP and President, EMEA	Dec 09 '24	Sale	219.03	638	139,741	14,217	Dec 10 08:23 PM
Neal Shana Carol	EVP and Chief People Officer	Dec 06 '24	Sale	220.49	1,000	220,490	16,989	Dec 10 08:17 PM
ROLAND GOETTE	Officer	Dec 09 '24	Proposed Sale	220.02	638	140,373		Dec 09 04:47 PM
Shan David	EVP and Chief ISC Officer	Dec 05 '24	Sale	220.25	1,500	330,375	6,285	Dec 06 04:55 PM
ROLAND GOETTE	Officer	Dec 06 '24	Proposed Sale	222.24	4,483	996,302		Dec 06 04:31 PM
SHANA NEAL	Officer	Dec 06 '24	Proposed Sale	222.24	1,000	222,240		Dec 06 04:31 PM
DAVID SHAN	Officer	Dec 05 '24	Proposed Sale	221.43	1,500	332,145		Dec 05 04:42 PM
BURZIK CATHERINE M	Director	Sep 16 '24	Proposed Sale	235.78	400	94,312		Sep 16 11:52 AM
Goette Roland	EVP and President EMEA	Aug 14 '24	Option Exercise	132.54	5,295	701,799	16,603	Aug 15 01:47 PM
Spoerel Thomas J	SVP,Controller&Chief Acct Off	Jun 10 '24	Sale	239.31	300	71,793	1,976	Jun 11 01:45 PM
Goette Roland	EVP and President EMEA	May 15 '24	Sale	236.73	3,300	781,224	11,308	May 16 07:54 PM
Goette Roland	EVP and President EMEA	May 13 '24	Sale	236.70	3,300	781,121	14,608	May 15 02:44 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Becton Dickinson & Co

Upgrade your FINVIZ experience